CR Biotech Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
2
- Portfolio
-
1
- Exits
-
2
CR Biotech General Information
Company Description
CR Biotech is a venture capital firm based in San Diego, California.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- San Diego, CA
- United States
CR Biotech Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Arthrosi Therapeutics | 23-Jun-2025 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Viva Vision Biotech | 18-Feb-2020 | Drug Discovery | Generating Revenue |
CR Biotech Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Arthrosi Therapeutics | 09-Feb-2026 |
CR Biotech Investments by Industry, Year, and Region
CR Biotech Co-Investors (8)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| H7 BioCapital | 1 |
|
|
||
| HM Venture Partners |
|
|
|||
| Highlight Capital Partners |
|
|
|||
| Maxpro Ventures |
|
|
|||
| Viva Ventures Biotech Group |
|
|
CR Biotech FAQs
-
What is CR Biotech?
CR Biotech is a venture capital firm based in San Diego, California.
-
Where is CR Biotech headquartered?
CR Biotech is headquartered in San Diego, CA.
-
How many investments has CR Biotech made?
CR Biotech has made 2 investments.
-
What has CR Biotech invested in?
CR Biotech has made numerous investments in companies like Arthrosi Therapeutics and Viva Vision Biotech within the Drug Discovery industry.
-
What has CR Biotech invested in recently?
CR Biotech's latest investment was on 23-Jun-2025 in Arthrosi Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process